CM/PHR/23/5701- NHS National Framework for Natalizumab-February 2024

A Contract Award Notice
by NHS ENGLAND

Source
Contracts Finder
Type
Framework (Products)
Duration
19 month
Value
£64M
Sector
HEALTH
Published
02 Feb 2024
Delivery
01 Feb 2024 to 31 Aug 2025
Deadline
04 Dec 2023 13:00

Concepts

Location

Geochart for 1 buyers and 2 suppliers

1 buyer

2 suppliers

Description

NHS National Framework for Natalizumab - February 2024 Offer reference number: CM/PHR/23/5701 Period of framework: 1 February 2024 to 31 August 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.

Award Detail

1 Sandoz (Camberley)
  • Value: £63,746,000
2 Biogen (Maidenhead)
  • Value: £63,746,000

CPV Codes

  • 33600000 - Pharmaceutical products

Indicators

  • Contract is suitable for SMEs.

Other Information

Document No. 03 - Framework Agreement and Terms and Conditions Document No. 03 - Framework Agreement and Terms and Conditions.docx Transparency Award Schedules - CM_PHR_23_5701 Transparency Award Schedules - CM_PHR_23_5701.pdf CMPHR235701 - Parties Appointed to the framework - Natalizumab CMPHR235701 - Parties Appointed to the framework - Natalizumab.xlsx FTS 2023_S 000-032448 - PUBLISHED OPPORTUNITY - Natalizumab - 032448-2023 FTS 2023_S 000-032448 - PUBLISHED OPPORTUNITY - Natalizumab - 032448-2023.pdf Document No. 10 - Pharmacy Purchasing Points List - CM-PHR-23-5701 Document No. 10 - Pharmacy Purchasing Points List - CM-PHR-23-5701.xls

Reference

Domains